TMR observes global chlamydia infection diagnostics and therapeutics market is fairly consolidated due to presence of strong players. The top five players operating the diagnostics accounts for the larger share of nearly equal to 58% while players operating in the therapeutics accounts for nearly 24%. There are numerous companies are operating in the market, however,… Chlamydia testing identifies the bacteria Chlamydia trachomatis as the cause of your infection. The preferred method for chlamydia testing is the nucleic acid amplification test (NAAT) that detects the genetic material (DNA) of Chlamydia trachomatis. It is generally more sensitive and specific than other chlamydia tests and can be performed on a vaginal swab on women or urine from both men and. Chlamydia infection has a high frequency of transmission, with concordance rates of up to 75% of partners being reported. Although no test is 100% sensitive or specific, NAATs are known to be more sensitive and specific than EIAs. Vulvo-vaginal swabs (VVS): A vulvo-vaginal sample is the specimen of choice in women (Level IIa, Grade B). Endocervical swabs: These have been shown to be less. Chlamydia infection has a high frequency of trans-mission, with concordance rates of up to 75% of part-. Although no test is 100% sensitive or specific, NAATs are known to be more sensitive and specific than EIAs.68 Screening using EIA is no longer accept-able (Level IIa, Grade B). There has been considerable debate as to whether a single reactive NAAT requires further confirmation. NAATs are highly sensitive, can be used in non-clinical settings and are the only recommended test for chlamydia. For asymptomatic testing or where an examination is unable to be performed, encourage patient self-collection of vaginal swabs and anorectal swabs. Concurrent gonorrhoea testing should accompany chlamydia testing. Clinical indicators for testing. Test for chlamydia in any of the. Cell culture and subsequent detection of Chlamydia trachomatis by fluorescent antibody staining. CPT coding for microbiology and virology procedures often cannot be determined before the culture is performed. Requests with only a written order and no test number indicated will be processed according to Default Testing for Virology. Special Instructions. Submit one specimen per test requested. Chlamydia trachomatis (/ k l ə ˈ m ɪ d i ə t r ə ˈ k oʊ m ə t ɪ s /), commonly known as chlamydia, is a bacterium that causes chlamydia, which can manifest in various ways, including: trachoma, lymphogranuloma venereum, nongonococcal urethritis, cervicitis, salpingitis, pelvic inflammatory disease. C. trachomatis is the most common infectious cause of blindness and the most common. Chlamydia trachomatis. infections, 1993. MMWR 1993;42[No. RR-12]:1–39), nucleic acid amplification tests (NAATs) have been introduced as critical new tools to diagnose and treat. C. trachomatis. and. Neisseria gonorrhoeae. infections. NAATs for. C. trachomatis. are substantially more sensitive than previous tests. When using a NAAT, any. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay. J Clin Microbiol. 1997;35(6):1536–1540. Chlamydia pneumoniae (TWAR organism) has been found only in humans. The chlamydiae are a small group of nonmotile coccoid bacteria that are obligate intracellular parasites of eukaryotic cells. Chlamydial cells are unable to carry out energy metabolism and lack many biosynthetic pathways; therefore they are entirely dependent on the host cell to supply them with ATP and other intermediates.